(lp0
S"Trading Options During Earnings in Synergy Pharmaceuticals Inc  CML News - 10 hours ago We're going to examine buying and selling out of the money strangles in Synergy Pharmaceuticals Inc and find out once and for all what the winning trades have been during earnings releases."
p1
aS"Synergy's Trulance Looking Like The Next Uceris Seeking Alpha - Mar 13, 2017 Synergy Pharmaceuticals , a gastrointestinal company out of New York, was recently approved for their drug Trulance.Synergy Pharmaceuticals: Approval, Now What? - Bloomington Pantagraph"
p2
aS"Canaccord Chimes in on Synergy Pharmaceuticals Inc  as It Prepares for ... Smarter Analyst - Mar 2, 2017 Yesterday, Synergy Pharmaceuticals Inc  reported fourth-quarter financial results and reiterated the launch of Trulance , Synergy's recently-approved lead drug, for treatment of chronic idiopathic constipation , which is&nbsp;...CORRECTING and REPLACING Synergy Pharmaceuticals Reports Fourth Quarter and ... - Yahoo FinanceSynergy Pharmaceuticals Inc.  Plunges 5.46% on March 02 - Equities.com"
p3
aS'Synergy Pharmaceuticals Inc  Releases Q4 and Full-Year Financial Results Smarter Analyst - Mar 1, 2017 Synergy Pharmaceuticals Inc  reported its financial results and business update for the full year and the three months ended December 31, 2016.'
p4
aS"Synergy Pharmaceuticals to Present at Oppenheimer 27th Annual Healthcare ... Yahoo Finance - Mar 14, 2017 Synergy Pharmaceuticals Inc.  today announced that Marino Garcia, the company's EVP and Chief Strategy Officer, will present a corporate update at the Oppenheimer 27th Annual Healthcare Conference on Tuesday, March 21, 2017 at 11:30 a.m.&nbsp;..."
p5
aS"Synergy Pharmaceuticals Inc.  Moves Lower on Volume Spike for March 17 Equities.com - Mar 17, 2017 Synergy Pharmaceuticals Inc.  traded on unusually high volume on Mar. 17, as the stock lost 3.43% to close at $5.07. On the day, Synergy Pharmaceuticals Inc. saw 22.18 million shares trade hands on 34,812 trades. Considering that the stock&nbsp;...Synergy Pharmaceuticals Inc.  Files An 8-K Other Events - Market ExclusiveWhat are Analyst's Indicators for Synergy Pharmaceuticals Inc. , Range ... - The USA Commerce"
p6
aS'The Technical Charts For Synergy Pharmaceuticals Inc.  Say It All Today NY Stock News - 18 hours ago The technicals for Synergy Pharmaceuticals Inc.  have taken shape, and with them a comprehensive picture has emerged.'
p7
aS'Technical Review on Shares of Synergy Pharmaceuticals Inc  Davidson Register - 15 hours ago When applying indicators for technical analysis, traders and investors might want to examine the ATR or Average True Range. The current 14-day ATR for Synergy Pharmaceuticals Inc  is currently sitting at 0.27. The ATR basically measures the&nbsp;...'
p8
aS"Latest Updates :Synergy Pharmaceuticals Inc.'s  stock price is Worth at ... Hot Stocks Point - 14 hours ago Synergy Pharmaceuticals Inc.  stock price ended its day with loss -3.43% and finalized at the price of $5.07. During its last trading session, Stock traded with the total exchanged volume of 22.33 million shares.Should You Buy, Sell, Or Hold?  Synergy Pharmaceuticals Inc. , The ... - USA Commerce DailyROE of Synergy Pharmaceuticals, Inc.  stands at -876.7 - TopChronicle"
p9
aS'Synergy: 3 Scenarios, 1 Choice Seeking Alpha - Feb 24, 2017 Synergy Pharmaceuticals  is a biopharmaceutical company focused on the treatment of gastrointestinal diseases and disorders.'
p10
a.